Genepoint Biological Technology

Shanghai, China Founded: 2015 • Age: 11 yrs
Platform for cryostorage and long-term biological preservation is provided.
Request Access

About Genepoint Biological Technology

Genepoint Biological Technology is a company based in Shanghai (China) founded in 2015.. Genepoint Biological Technology has raised $48.3 million across 4 funding rounds from investors including MGI Tech, New Hope Group and Zhongke Guosheng. Genepoint Biological Technology operates in a competitive market with competitors including Brooks Automation, Bridge to Life, Hemanext, Atelerix and Cellbox Solutions, among others.

  • Headquarter Shanghai, China
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $48.3 M (USD)

    in 4 rounds

  • Latest Funding Round
    $29.54 M (USD), Series D

    Jan 18, 2023

  • Investors
    MGI Tech

    & 8 more

  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Genepoint Biological Technology

Genepoint Biological Technology has successfully raised a total of $48.3M across 4 strategic funding rounds. The most recent funding activity was a Series D round of $29.54 million completed in January 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 4
  • Last Round Series D — $29.5M
  • First Round
  • Investors Count 9
Date Amount Transaction Name Valuation Lead Investors Investors
Jan, 2023 Amount Series D - Genepoint Biological Technology Valuation Shanghai Guofang Private Equity Fund Management
Jul, 2021 Amount Series C - Genepoint Biological Technology Valuation

investors

MGI
Jun, 2021 Amount Series C - Genepoint Biological Technology Valuation Northern Light Venture Capital , New Hope Group
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Genepoint Biological Technology

Genepoint Biological Technology has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include MGI Tech, New Hope Group and Zhongke Guosheng. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
-
Founded Year Domain Location
Provider of early stage venture capital focused on technology companies
Founded Year Domain Location
Chinese startups are funded and incubated by Legend Star.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Genepoint Biological Technology

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Genepoint Biological Technology

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Genepoint Biological Technology Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Genepoint Biological Technology

Genepoint Biological Technology operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Brooks Automation, Bridge to Life, Hemanext, Atelerix and Cellbox Solutions, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Vacuum robots for semiconductor wafer handling are developed.
domain founded_year HQ Location
Cold storage solutions for organ transplant preservation are provided.
domain founded_year HQ Location
Technologies for blood and product storage are developed.
domain founded_year HQ Location
Technology for cell storage and transportation is developed.
domain founded_year HQ Location
Portable devices for cell storage and transport are provided.
domain founded_year HQ Location
Thermal packaging solutions and cold chain monitoring services are provided.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Genepoint Biological Technology

Frequently Asked Questions about Genepoint Biological Technology

When was Genepoint Biological Technology founded?

Genepoint Biological Technology was founded in 2015 and raised its 1st funding round 3 years after it was founded.

Where is Genepoint Biological Technology located?

Genepoint Biological Technology is headquartered in Shanghai, China.

Who is the current CEO of Genepoint Biological Technology?

Ding Fubin is the current CEO of Genepoint Biological Technology.

Is Genepoint Biological Technology a funded company?

Genepoint Biological Technology is a funded company, having raised a total of $48.3M across 4 funding rounds to date. The company's 1st funding round was a Series C of $18.75M, raised on Aug 24, 2018.

What does Genepoint Biological Technology do?

Genepoint Biological Technology was founded in 2015 and is based in Shanghai, China. Operations focus on the biotechnology sector, where a platform for cryostorage and long-term preservation is developed. Key products include a cryogenic cell storage automation system, a flexible robot for biobanking, a LIN vapor cryo-freezer, and a hoist for freezer handling. These solutions support biobanking and preservation needs in research and medical applications.

Who are the top competitors of Genepoint Biological Technology?

Genepoint Biological Technology's top competitors include Brooks Automation, Hemanext and Bridge to Life.

Who are Genepoint Biological Technology's investors?

Genepoint Biological Technology has 9 investors. Key investors include MGI Tech, New Hope Group, Zhongke Guosheng, Huajin Capital, and Shanghai Guofang Private Equity Fund Management.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available